BACKGROUND: Because of its wide spectrum of clinical manifestations and its well-defined immunological complications, leprosy is a useful disease for studying genetic regulation of the host response to infection. We hypothesized that polymorphisms in the nucleotide-binding oligomerization domain containing 2 (NOD2) gene, for a cytosolic receptor known to detect mycobacteria, are associated with susceptibility to leprosy and its clinical outcomes. METHODS: We used a case-control study design with 933 patients in Nepal. Our study included 240 patients with type 1 (reversal) reactions and 124 patients with type 2 (erythema nodosum leprosum) reactions. We compared the frequencies of 32 common polymorphisms in the NOD2 gene region between patients with the different clinical types of leprosy as well as between the patients and 101 control participants without leprosy. RESULTS: Four polymorphisms were associated with susceptibility to leprosy when comparing allele frequencies, and 8 were associated when comparing genotype frequencies with a dominant model. Five polymorphisms were associated with protection from reversal reaction in an allelic analysis, and 7 were associated with reversal reaction with a dominant model. Four polymorphisms were associated with increased susceptibility to erythema nodosum leprosum in an allelic analysis, whereas 7 of 32 polymorphisms were associated with a dominant model. CONCLUSION: These data suggest that NOD2 genetic variants are associated with susceptibility to leprosy and the development of leprosy reactive states.
BACKGROUND: Because of its wide spectrum of clinical manifestations and its well-defined immunological complications, leprosy is a useful disease for studying genetic regulation of the host response to infection. We hypothesized that polymorphisms in the nucleotide-binding oligomerization domain containing 2 (NOD2) gene, for a cytosolic receptor known to detect mycobacteria, are associated with susceptibility to leprosy and its clinical outcomes. METHODS: We used a case-control study design with 933 patients in Nepal. Our study included 240 patients with type 1 (reversal) reactions and 124 patients with type 2 (erythema nodosum leprosum) reactions. We compared the frequencies of 32 common polymorphisms in the NOD2 gene region between patients with the different clinical types of leprosy as well as between the patients and 101 control participants without leprosy. RESULTS: Four polymorphisms were associated with susceptibility to leprosy when comparing allele frequencies, and 8 were associated when comparing genotype frequencies with a dominant model. Five polymorphisms were associated with protection from reversal reaction in an allelic analysis, and 7 were associated with reversal reaction with a dominant model. Four polymorphisms were associated with increased susceptibility to erythema nodosum leprosum in an allelic analysis, whereas 7 of 32 polymorphisms were associated with a dominant model. CONCLUSION: These data suggest that NOD2 genetic variants are associated with susceptibility to leprosy and the development of leprosy reactive states.
Authors: Nicole van der Wel; David Hava; Diane Houben; Donna Fluitsma; Maaike van Zon; Jason Pierson; Michael Brenner; Peter J Peters Journal: Cell Date: 2007-06-29 Impact factor: 41.582
Authors: A C Pereira; V N Brito-de-Souza; C C Cardoso; I M F Dias-Baptista; F P C Parelli; J Venturini; F R Villani-Moreno; A G Pacheco; M O Moraes Journal: Genes Immun Date: 2008-12-25 Impact factor: 2.676
Authors: Gerben Ferwerda; Stephen E Girardin; Bart-Jan Kullberg; Lionel Le Bourhis; Dirk J de Jong; Dennis M L Langenberg; Reinout van Crevel; Gosse J Adema; Tom H M Ottenhoff; Jos W M Van der Meer; Mihai G Netea Journal: PLoS Pathog Date: 2005-11-25 Impact factor: 6.823
Authors: Elizabeth A Misch; Murdo Macdonald; Chaman Ranjit; Bishwa R Sapkota; Richard D Wells; M Ruby Siddiqui; Gilla Kaplan; Thomas R Hawn Journal: PLoS Negl Trop Dis Date: 2008-05-07
Authors: Ana Paula Vieira; Maria Ângela Bianconcini Trindade; Carla Pagliari; João Avancini; Neusa Yurico Sakai-Valente; Alberto José da Silva Duarte; Gil Benard Journal: Am J Trop Med Hyg Date: 2016-02-22 Impact factor: 2.345
Authors: Mirjam Schenk; Stephan R Krutzik; Peter A Sieling; Delphine J Lee; Rosane M B Teles; Maria Teresa Ochoa; Evangelia Komisopoulou; Euzenir N Sarno; Thomas H Rea; Thomas G Graeber; Soohyun Kim; Genhong Cheng; Robert L Modlin Journal: Nat Med Date: 2012-03-25 Impact factor: 53.440
Authors: Bishwa R Sapkota; Murdo Macdonald; William R Berrington; E Ann Misch; Chaman Ranjit; M Ruby Siddiqui; Gilla Kaplan; Thomas R Hawn Journal: Hum Immunol Date: 2010-08-01 Impact factor: 2.850
Authors: Tiffany C Scharschmidt; Erin H Amerson; Oren S Rosenberg; Richard A Jacobs; Timothy H McCalmont; Kanade Shinkai Journal: JAMA Dermatol Date: 2013-01 Impact factor: 10.282
Authors: Nicolle D Myers; Narisara Chantratita; William R Berrington; Wirongrong Chierakul; Direk Limmathurotsakul; Vanaporn Wuthiekanun; Johanna D Robertson; H Denny Liggitt; Sharon J Peacock; Shawn J Skerrett; T Eoin West Journal: J Immunol Date: 2013-12-02 Impact factor: 5.422